Committed to providing scientific clarity to MS care, we are proud to launch our new blog: Octave Note

Biology

From subjectivity to objective biological measurements

The first and only multivariate biomarker blood test

that provides accurate measurement of MS disease activity.

TODAY

No data at the biological level

With current tools, changes in MS disease activity are often invisible—until it’s too late.

WITH OCTAVE

Real-time insight
for faster, smarter intervention

We’re changing that.
Introducing our first-in-class disease activity blood test, which provides real-time assessment of the underlying biology, pathways, mechanisms, and cell types involved in a patient’s MS.

WITH OCTAVE

Dynamic, multianalyte
approach

Our multi-protein assay is a dynamic measure of immune modulation, inflammation, myelin biology, and neuroaxonal integrity validated through an extensive R&D process and clinical study.

WITH OCTAVE

Address real, debilitating issues in MS care

Finally, a solution to quantitatively measure subclinical disease activity and detect relapses that can be used to identify suboptimal responses to current interventions. This is only the beginning—we’re at work
on other serum-based biomarker tests to bring additional insights to light.

Key Applications

The Octave disease activity test helps you
Support DMT selection based on disease phenotype

Conduct routine surveillance

Evaluate stability vs. slow decline

Monitor new symptoms - evaluation for relapse

Identify stable patients who can potentially stop DMT

The Octave Bioscience Clinical Laboratory is certified under the Clinical Laboratory Improvement Act of 1988 (CLIA) as qualified to perform high complexity clinical testing and is a College of American Pathology (CAP) Accredited Laboratory.

CLIA ID #05D2168340

CLIA

See the Science

Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights

Research Presented at the Annual CMSC Meeting — June 1-4, 2022

Download PDF  

Analytical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Download PDF  
View All Publications  

Get In Touch

Please reach out and we’ll be in touch soon.







 

*Required field

By submitting your information, you agree to receive emails from Octave and understand that you may opt out of Octave subscriptions at any time.